Error message

Warning: Use of undefined constant openphil_social - assumed 'openphil_social' (this will throw an Error in a future version of PHP) in openphil_social_block_block_view() (line 90 of /var/www/html/openphil/live/sites/all/modules/custom/openphil_social_block/openphil_social_block.module).

Kainomyx — Antimalarial Drug (2021)

Organization Name 
Award Date 
9/2021
Grant Amount 
$4,000,000
Purpose 
To develop and produce new drugs to treat malaria and other parasitic diseases, such as cryptosporidiosis and toxoplasmosis.
Topic (focus area) 

Grant Investigators: Heather Youngs and Chris Somerville

This page was reviewed but not written by the grant investigators. Kainomyx staff also reviewed this page prior to publication.

Open Philanthropy recommended an investment of $4,000,000 in Kainomyx to develop and produce new drugs to treat malaria and other parasitic diseases, such as cryptosporidiosis and toxoplasmosis. If effective, the new drugs would act by inhibiting cytoskeletal proteins in malarial and other parasites. Our science team believes that there is a need for new antimalarial drugs due to increasing resistance to existing treatments.

This follows our May 2020 investment and falls within our work on scientific research, specifically within our interest in advancing human health and wellbeing.